Syngeneic Models

Charles River offers a broad range of syngeneic models that can be used to screen immunobiological therapies.

Histotype Cell Line
Breast 4T1
Colon Colon26, CT26, MC38
Fibrosarcoma WEHI164
Glioma GL261
Hepatoma Hepa1-6, Yoshida
Leukemia L1210, P388
Lung LL, LLMET, Madison109
Lymphoma A20, EL4, L5178-R
Melanoma B16F0, B16F10, CloudmanS91
Ovarian M5076
Pancreatic PAN02
Renal Renca
Sarcoma EHS

You may also be interested in...

In Vitro ADMET

Our wide range of automated in vitro assays yields information in the areas of metabolism, toxicity and physicochemical characteristics.

Biomarker Services

We can support your drug discovery pipeline by providing biomarker analysis in a non-GxP environment.

Hematology Services

Charles River offers multiparameter diagnostic hematology analysis to assist in the identification of potential toxicities associated with agents.

Imaging Services

Our range of imaging modalities can dramatically increase the efficiency and significantly enhance the value of your in vivo study.